Investing

Vor Biopharma shareholders approve equity plan changes and reverse stock split authorization

Vor Biopharma Inc. (NASDAQ:VOR), a biotechnology company currently valued at $263 million, announced Wednesday that its shareholders approved several proposals at a special meeting held Monday, ...
Investing

Nexalin Technology shareholders elect directors and approve equity plan changes

Nexalin Technology , Inc. (NASDAQ:NXL), currently trading at $1.17 with a market capitalization of $17.6 million, reported the results of its annual meeting of shareholders, held Wednesday. According ...
Investing

Silexion Therapeutics shareholders approve board elections, reverse split and equity plan changes

Silexion Therapeutics Corp (NASDAQ:SLXN) announced Monday that shareholders approved all proposals at its reconvened 2025 annual general meeting after an initial adjournment on July 7 due to lack of ...
Reuters

Third Point Investors Limited shareholders approve Malibu acquisition, statement says

LONDON, Aug 14 (Reuters) - Shareholders of Third Point Investors Limited (TPOGu.L), opens new tab have voted in favour of a deal that will see the fund acquire Malibu Life Reinsurance SPC, a TPIL ...